Beijing, China

Chenggen Zhu

This inventor holds 1 USPTO granted patent. Top assignee: Chinese Academy of Sciences. Active years: 2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chenggen Zhu. Retrieved from https://idiyas.com/inventor/chenggen-zhu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 14.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2019

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Chenggen Zhu: Innovator in Pharmaceutical Chemistry

Introduction

Chenggen Zhu is a prominent inventor based in Beijing, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that address various neurological conditions. His work is characterized by a commitment to improving health outcomes through innovative solutions.

Latest Patents

Chenggen Zhu holds 1 patent related to N-substituted adenosine derivatives and N-substituted adenine derivatives. This patent outlines manufacturing methods for these compounds, as well as a pharmaceutical composition that includes them. The applications of these compounds are particularly noteworthy, as they are designed for treating insomnia, convulsions, epilepsy, and Parkinson's disease, while also preventing and treating dementia.

Career Highlights

Chenggen Zhu is affiliated with the Chinese Academy of Sciences, where he conducts his research and development activities. His work has garnered attention for its potential impact on the pharmaceutical industry and healthcare.

Collaborations

Chenggen Zhu collaborates with esteemed colleagues, including Jiachen Zi and Yafang Wang. Their combined expertise enhances the research efforts and innovation within their projects.

Conclusion

Chenggen Zhu's contributions to pharmaceutical chemistry exemplify the importance of innovation in addressing complex health issues. His work continues to pave the way for advancements in medical treatments and healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…